Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.
≥ 60 years of age at screening [+7]
Any known anatomic issues that could prevent placement of iFuse TORQ TNT [+13]